Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Further Validation of the Memory Orientation Screening Test (MOST):A 5-minute Screening Test for Dementia in Primary Care Practice

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2010 by Clionsky, Mitchell, Ph.D., ABPP(CN).
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Clionsky, Mitchell, Ph.D., ABPP(CN)
ClinicalTrials.gov Identifier:
NCT01057602
First received: January 23, 2010
Last updated: February 7, 2010
Last verified: January 2010
  Purpose

The purpose of this study is to apply a recently developed screening test for dementia, the Memory Orientation Screening Test (MOST) to two additional groups. Group one is composed of 150 elders who do not have dementia and are residing in the community so that we can determine what is a "normal" MOST score. These subjects will also be individually administered a one-hour battery composed of other commonly used tests of memory and information processing. Group two is composed of 150 elders who are administered the MOST by a nurse as part of their regular visit to the primary care doctor's office, and their scores will be compared against a rating of their cognitive ability made independently by the doctor or another nurse. Their scores will also be compared with a list of their medical problems and medications. Our hypothesis for the first group is that the MOST scores will be higher in the normal group than in the previous clinical groups and that MOST scores will correlate significantly with other neurocognitive tests. Our hypothesis for the second group is that the MOST can be administered quickly and easily by briefly trained nurses, that it will compare highly with doctor opinions, and that patients with known medical conditions related to dementia, such as hypertension or diabetes, will have lower MOST scores than patients in better health.


Condition
Dementia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Further Validation of the Memory Orientation Screening Test (MOST): A 5-minute Screening Test for Dementia in Primary Care Practice

Resource links provided by NLM:


Further study details as provided by Clionsky, Mitchell, Ph.D., ABPP(CN):

Primary Outcome Measures:
  • Memory Orientation Screening Test score [ Time Frame: Day 1 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Other neuropsychological test scores and doctor ratings [ Time Frame: Day 1 ] [ Designated as safety issue: No ]

Estimated Enrollment: 300
Study Start Date: May 2008
Estimated Study Completion Date: September 2010
Estimated Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
Normal community dwelling elders
Individuals age 65 and older who live in the community

  Eligibility

Ages Eligible for Study:   65 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Community sample and primary care clinic

Criteria

Inclusion Criteria:

  • Age 65 or older

Exclusion Criteria:

  • Younger than 65,
  • diagnosed with dementia,
  • blind,
  • non-English speaking
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01057602

Locations
United States, Massachusetts
Clionsky Neuro Systems, LLC Recruiting
Springfield, Massachusetts, United States, 01105
Contact: Mitchell I Clionsky, Ph.D.    413-734-1799    clionsky@braindoc.com   
Contact: Emilymarie Clionsky, M.D.    413-734-1799    emily4cns@comcast.net   
Principal Investigator: Mitchell I Clionsky, Ph.D.         
Sponsors and Collaborators
Clionsky, Mitchell, Ph.D., ABPP(CN)
Investigators
Principal Investigator: Mitchell I Clionsky, Ph.D. Clionsky Neuro Systems
  More Information

No publications provided

Responsible Party: Mitchell Clionsky, Ph.D., Clionsky Neuro Systems, LLC
ClinicalTrials.gov Identifier: NCT01057602     History of Changes
Other Study ID Numbers: SP2008-004
Study First Received: January 23, 2010
Last Updated: February 7, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Clionsky, Mitchell, Ph.D., ABPP(CN):
Dementia
Screening Tests
Cognition
Memory
MOST

Additional relevant MeSH terms:
Dementia
Brain Diseases
Central Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Nervous System Diseases

ClinicalTrials.gov processed this record on November 25, 2014